Company / FCF Margin
Sanara MedTech Inc. FCF Margin History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-0.3%
FY2025
5-year range
-29.4% / -0.3%
FY2021-FY2025
Trend
+95.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has increased for 4 consecutive years, from -29.4% in FY2021 to -0.3% in FY2025.
Based on SEC 10-K filings.
-0.3% in FY2025 with a 10-year CAGR of +64.1%.
Improved from -12.4% to -0.3% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +20.4pp
- 5-Year Change
- +19.7pp
- 10-Year Change
- +64.1pp
Key checks
Key Insights
- Sanara MedTech Inc.'s fcf margin has grown for 4 consecutive years.
- In FY2025, fcf margin increased 95.2% year-over-year.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2015.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -0.3% | +95.2% |
| FY2024 | -5.4% | +56.6% |
| FY2023 | -12.4% | +39.8% |
| FY2022 | -20.6% | +29.7% |
| FY2021 | -29.4% | -47.1% |
| FY2020 | -20.0% | -586.3% |
| FY2018 | -2.9% | -139.4% |
| FY2017 | 7.4% | +120.6% |
| FY2016 | -35.8% | +44.3% |
| FY2015 | -64.4% | +40.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026